U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
187231187231Study Of Alvimopan Drug For Treatment Of Constipation Due To Prescription Pain MedicationCompletedNo Results AvailableConstipation|Bowel DysfunctionDrug: alvimopan|Drug: placebohttps://ClinicalTrials.gov/show/NCT00101998
187232187232Eight-Weeks Of Treatment With Talnetant In Subjects With Irritable Bowel Syndrome (IBS)CompletedNo Results AvailableIrritable ColonDrug: talnetanthttps://ClinicalTrials.gov/show/NCT00101985
187233187233RAV12 in Treating Patients With Metastatic or Recurrent AdenocarcinomaCompletedNo Results AvailableCancerBiological: monoclonal antibody RAV12https://ClinicalTrials.gov/show/NCT00101972
187234187234Implementation Study of Treatment Optimization Recommendations on Relapsing-Remitting Multiple Sclerosis (RR MS) SubjectsWithdrawnNo Results AvailableRelapsing-Remitting Multiple SclerosisDrug: Rebifhttps://ClinicalTrials.gov/show/NCT00101959
187235187235Nine-Weeks Treatment With 683699 In Subjects With Moderately-To-Severely Active Crohn's DiseaseCompletedNo Results AvailableCrohn's DiseaseDrug: 683699https://ClinicalTrials.gov/show/NCT00101946
187236187236SANTE - Stimulation of the Anterior Nucleus of the Thalamus for EpilepsyActive, not recruitingHas ResultsEpilepsyDevice: Medtronic DBS Therapy for epilepsy|Device: Medtronic DBS Therapy for epilepsyhttps://ClinicalTrials.gov/show/NCT00101933
187237187237ABX-EGF as Second Line Treatment of Advanced Non-Small-Cell Lung Cancer (NSCLC)CompletedNo Results AvailableNon-small Cell Lung Cancer|Neoplasm Metastasis|Lung CancerDrug: ABX-EGFhttps://ClinicalTrials.gov/show/NCT00101920
187238187238Safety of AMG 706 Plus Panitumumab Plus Gemcitabine-Cisplatin in the Treatment of Patients With Advanced CancerTerminatedHas ResultsLung Cancer|Pancreatic Cancer|Esophageal CancerDrug: AMG 706|Biological: Panitumumab|Drug: Gemcitabine|Drug: Cisplatinhttps://ClinicalTrials.gov/show/NCT00101907
187239187239Safety of AMG 706 Plus Panitumumab Plus Chemotherapy in the Treatment of Subjects With Metastatic Colorectal CancerCompletedNo Results AvailableRectal Cancer|Colon CancerDrug: FOLFOX-4|Drug: AMG 706|Biological: Panitumumab (Part 1a only)|Drug: FOLFIRIhttps://ClinicalTrials.gov/show/NCT00101894
187240187240Transthoracic Incremental Monophasic Versus Biphasic by Emergency Responders (TIMBER)CompletedNo Results AvailableCardiac ArrestDevice: Defibrillation (biphasic versus monophasic shock)https://ClinicalTrials.gov/show/NCT00101881
187241187241Value of Technology to Transfer Discharge InformationCompletedHas ResultsInformation Dissemination|Interprofessional RelationsDevice: Discharge communication software|Other: Usual care discharge processhttps://ClinicalTrials.gov/show/NCT00101868
187242187242Can Parental Activation Over the Internet Improve Pediatric Preventive Care?Active, not recruitingNo Results AvailableWell Child Preventive CareProcedure: An evidence based tailored web sitehttps://ClinicalTrials.gov/show/NCT00101855
187243187243Gemcitabine and Platinol Followed by Pemetrexed and Gemcitabine in Patients With Advanced or Metastatic Bladder CancerCompletedNo Results AvailableCarcinoma, Transitional CellDrug: Pemetrexed|Drug: Gemcitabine|Drug: Platinolhttps://ClinicalTrials.gov/show/NCT00101842
187244187244Anti-CD20 Antibody Therapy for Sjogren's SyndromeCompletedNo Results AvailableSjogren's SyndromeDrug: Rituximabhttps://ClinicalTrials.gov/show/NCT00101829
187245187245Dasatinib (BMS-354825) in Subjects With Myeloid Blast Phase Chronic Myeloid Leukemia Resistant to or Intolerant of Imatinib MesylateCompletedHas ResultsChronic Myeloid Leukemia|Blast CrisisDrug: Dasatinibhttps://ClinicalTrials.gov/show/NCT00101816
187246187246Efficacy and Safety of Vildagliptin in Combination With Pioglitazone in Drug Naive Patients With Type 2 DiabetesCompletedNo Results AvailableDiabetes Mellitus, Type 2Drug: vildagliptinhttps://ClinicalTrials.gov/show/NCT00101803
187247187247A Pilot Trial of Intravenous (IV) Pamidronate for Low Back PainActive, not recruitingNo Results AvailableLow Back PainDrug: pamidronatehttps://ClinicalTrials.gov/show/NCT00101790
187248187248Ventilatory Physiology in Children at Risk for AnxietyCompletedNo Results AvailableAnxiety|Panic Disorderhttps://ClinicalTrials.gov/show/NCT00101777
187249187249Intravitreal v. Sub-tenon Injections of Triamcinolone Acetonide for Macular Edema in Retinal DisordersCompletedNo Results AvailableMacular Degeneration|Retinal Vein Occlusion|Diabetic RetinopathyDrug: Triamcinolone Acetonidehttps://ClinicalTrials.gov/show/NCT00101764
187250187250INITIATE Plus (INITiation of Insulin to Reach A1c TargEt) StudyCompletedNo Results AvailableDiabetes|Diabetes Mellitus, Type 2Drug: biphasic insulin aspart|Behavioral: dietary regimenhttps://ClinicalTrials.gov/show/NCT00101751
187251187251Freedom Study: Myfortic in Kidney Transplant PatientsCompletedNo Results AvailableKidney TransplantationDrug: Myfortichttps://ClinicalTrials.gov/show/NCT00101738
187252187252A Study of Crofelemer to Treat Diarrhea Irritable Bowel SyndromeCompletedNo Results AvailableIrritable Bowel Syndrome|Colonic Diseases|Diarrhea|Gastrointestinal DiseaseDrug: crofelemerhttps://ClinicalTrials.gov/show/NCT00101725
187253187253Efficacy and Safety of Vildagliptin Compared to Placebo in Patients With Type 2 Diabetes and Mild HyperglycemiaCompletedNo Results AvailableDiabetes Mellitus, Type 2Drug: vildagliptin|Drug: Vildagliptin Placebohttps://ClinicalTrials.gov/show/NCT00101712
187254187254Effects of Soy Consumption on Symptoms of MenopauseCompletedNo Results AvailableMenopausehttps://ClinicalTrials.gov/show/NCT00101699
187255187255Trial Of Irinotecan In Combination With Three Methods Of Administration Of Fluoropyrimidine.CompletedHas ResultsColorectal NeoplasmsDrug: Modified Bolus 5-FU/LV with Irinotecan|Drug: FOLFIRI + bevacizumab|Drug: miFL + bevacizumab|Drug: Infusional 5-FU/LV with Irinotecan|Drug: Oral Capecitabine with Irinotecanhttps://ClinicalTrials.gov/show/NCT00101686
187256187256Efficacy and Safety of Vildagliptin in Patients With Type 2 Diabetes With HbA1c 9-11%CompletedNo Results AvailableDiabetes Mellitus, Type 2Drug: vildagliptinhttps://ClinicalTrials.gov/show/NCT00101673
187257187257Study of BMS-354825 (Dasatinib) in Patients With Chronic Myeloid Leukemia Who Are Either Resistant or Intolerant to ImatinibCompletedHas ResultsChronic Myeloid Leukemia|Philadelphia-Positive Myeloid LeukemiaDrug: Dasatinibhttps://ClinicalTrials.gov/show/NCT00101660
187258187258Study of Dasatinib (BMS-354825) in Patients With Accelerated Phase Chronic Myeloid LeukemiaCompletedHas ResultsChronic Myelogenous LeukemiaDrug: Dasatinibhttps://ClinicalTrials.gov/show/NCT00101647
187259187259Efficacy and Safety of a Long Acting Anti-Psychotic Versus Placebo in Patients With SchizophreniaCompletedNo Results AvailableSchizophreniaDrug: Paliperidone palmitatehttps://ClinicalTrials.gov/show/NCT00101634
187260187260Pilot Study to Evaluate the Safety and Analgesic Activity of M40403 Co-Administered With an Opioid Agent for Cancer PainTerminatedNo Results AvailableCancer|PainDrug: M40403https://ClinicalTrials.gov/show/NCT00101621

* Görseller ve İçerik tekif hakkına sahip olabilir